✦ LIBER ✦

The effects of calcitonin in hypercalcemia in patients with malignancy

✍ Scribed by Clarence B. Vaughn; Vainutis K. Vaitkevicius

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 345 KB
Volume: 34
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197410)34:4<1268::aid-cncr2820340437>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antipyretic effect of indomethacin in pa

Antipyretic effect of indomethacin in patients with malignancy

✍ Charles J. Lusch; Arthur A. Serpick; Lewis Slater 📂 Article 📅 1968 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 1 views

The antipyretic effect of indomethacin in 30 febrile patients with malignancy was evaluated. Effective antipyresis was observed in 20 of the 30 patients. Responses were usually prompt and complete and side effects were reported infrequently. Defervescence was obtained much more frequently in those

Incidence of hypercalcemia in patients w

Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center

✍ Rena Vassilopoulou-Sellin; Beverly M. Newman; Sarah H. Taylor; Vincent F. Guinee 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 1 views

Background. Hypercalcemia is a serious and not infrequent complication of malignant diseases; precise information about the incidence of hypercalcemia is not readily available. The study was designed to determine the incidence of hypercalcemia in patients with cancer. Methods. Retrospective analysi

Incidence of hypercalcemia in patients w

Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center

✍ Michael Huncharek; Rena Vassilopoulou-Sellin 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

## Incidence of Hypercalcemia in Patients with Malignancy Referred to a Comprehensive Cancer Center I read with interest the recent article by Dr. Vassilopoulou-Sellin et al.' regarding the incidence of hypercalcemia among cancer patients. The overall incidence of this complication was low in the

Malignancy in patients with sickle cell

Malignancy in patients with sickle cell disease

✍ William H. Schultz; for the International Association of Sickle Cell Nurses; Phy 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

A study of prostaglandin E2, parathormon

A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy

✍ Dean E. Brenner; Harold A. Harvey; Allan Lipton; Lawrence Demers 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 1 views

Pulmonary side effects of interferon-α t

Pulmonary side effects of interferon-α therapy in patients with hematological malignancies

✍ Patrik Anderson; Martin Höglund; Stig Rödjer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## Abstract Several side effects of interferon‐α‐2b (IFN‐α) therapy have been described. Pulmonary side effects have seldom been reported. The four patients we describe all developed respiratory disorders while being treated with IFN‐α for hematological malignancies. We point out the similarities a